Search results - 460 results

Efficacy and safety of camostat mesylate in early COVID-19 disease in an ambulatory setting: a randomized placebo-controlled phase II trial.

assigned in a 2:1 ratio to receive either camostat mesylate or a placebo. Outcomes included change in nasopharyngeal viral load, time to clinical improvement, the presence of neutralizing antibodies ...

Porcine Reproductive and Respiratory Syndrome virus (PRRSv): A Cross-Sectional Study on ELISA Seronegative, Multivaccinated Sows

(prevalence–origin–consequences) was not yet investigated. In this study, the prevalence of ELISA non-responders was assessed by measuring PRRS v-specific antibodies in 1400 sows, originating from 70 PRRS v-vaccinating sow herds, ...

Risks related to a possible reduction of the waiting period for dogs after rabies antibody titration to 30 days compared with 90 days of the current EU legislative regime.

Vuta, Vlad; Antoniou, Sotiria-Eleni; Aznar, Inma; Papanikolaou, Alexandra; Roberts, Helen Clare Source: EFSA J, Volume 20, Issue 6 (2022) Keywords: Antibody Dogs EU Pets Rabies serology Travel Abstract: ...

Outbreaks of Foot-and-Mouth Disease in Burundi, East Africa, in 2016, Caused by Different Serotypes.

blood were collected in six of the affected provinces spread over the country. The overall seroprevalence of FMD virus (FMDV) in the affected herds, as determined by antibodies against FMDV non-structural ...

Prevalence of anti-SARS-CoV-2 antibodies in the general population in Belgium: Results of the second data collection (28/09/21-23/02/22)

(2022) Keywords: antibodies COVID-19 health determinants population-based Seroprevalence Abstract: KEY FINDINGS Between the last period of wave 1 (14/06-11/07) and the first period of wave 2 (27/09-24/10) ...

Importance of anti-SARS-CoV-2 assay antigenic composition as revealed by the results of the Belgian external quality assessment (EQA) scheme.

Issue 2 (2022) Keywords: Adult Antibodies, Viral Antigens, Viral Belgium Coronavirus Nucleocapsid Proteins COVID-19 COVID-19 Serological Testing Diagnostic Tests, Routine Enzyme-Linked Immunosorbent Assay ...

Prevalence of Anti-SARS-CoV-2 Antibodies and Potential Determinants among the Belgian Adult Population: Baseline Results of a Prospective Cohort Study

Viruses, Volume 14, Issue 5 (2022) Keywords: SARS-CoV-2; COVID-19; antibodies; seroprevalence; cohort; population-based study; Belgium Abstract: The prevalence of anti- SARS-CoV-2 antibodies and potential ...

Pre-vaccination SARS-CoV-2 seroprevalence among staff and residents of nursing homes in Flanders (Belgium) in fall 2020

respiratory syndrome coronavirus 2 (SARS-CoV-2) IgG antibodies, using dried blood spots, was determined in October–November 2020, among residents and staff randomly selected from 20 nursing homes (NH) ...

Evaluation of dog vaccination schemes against rabies in Kinshasa, Democratic Republic of the Congo.

previously vaccinated since 1-2 years (n = 31), 2-3 years (n = 12) or 3-7.5 years (n = 4). Rapid Fluorescent Focus Inhibition Test was used to quantify antibodies. These data were used to implement vaccination ...

Poor antibody response to BioNTech/Pfizer COVID-19 vaccination in SARS-CoV-2 naïve residents of nursing homes.

SARS-CoV-2, were recruited in NH in Belgium before immunization with two doses of 30µg BNT162 b2 mRNA vaccine at day 0 and day 21. Binding antibodies (Ab) to SARS-CoV-2 receptor binding domain (RBD), spike ...

QR code

QR code for this page URL